XML 25 R17.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Net Loss Per Share | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Net Loss Per Share | 8. Net Loss Per Share The following table sets forth the computation of the basic and diluted net loss per share (in thousands, except share and per share amounts):
|  | Three Months Ended March 31, |
|  | 2024 |  |  | 2023 |
Numerator: |  |  |  |  |  |
Net loss |  | $ | (18,192 | ) |  | $ | (11,880 | )
Denominator: |  |  |  |  |  |
Weighted-average common shares outstanding |  |  | 52,275,451 |  |  |  | 42,690,767 |
Less: weighted-average unvested restricted common stock subject to repurchase |  |  | — |  |  |  | (3,274 | )
Less: weighted-average unvested common stock issued upon early exercise of common stock options |  |  | (46,517 | ) |  |  | (292,870 | )
Weighted-average shares used to compute net loss per common share, basic and diluted |  |  | 52,228,934 |  |  |  | 42,394,623 |
Net loss per share, basic and diluted |  | $ | (0.35 | ) |  | $ | (0.28 | )
Included in the weighted-average shares of common stock outstanding, both basic and diluted for the three months ended March 31, 2024 is a total of 6,087,230 common stock issuable upon the exercise of the 2024 Pre-Funded Warrants issued under the 2024 Private Placement (described in Note 6). The 2024 Pre-Funded Warrants are exercisable at any time for nominal consideration, and therefore these shares are considered outstanding for the purpose of calculating basic and diluted net loss per share. The following table sets forth the outstanding potentially dilutive securities that have been excluded from the calculation of diluted net loss per share because their inclusion would be anti-dilutive.
|  | As of March 31, |
|  | 2024 |  |  | 2023 |
Unvested restricted common stock subject to repurchase |  |  | — |  |  |  | 3,175 |
Unvested common stock upon early exercise of stock options |  |  | 46,517 |  |  |  | 225,581 |
Options to purchase common stock |  |  | 8,347,499 |  |  |  | 6,126,093 |
Estimated shares purchasable under the ESPP |  |  | 2,913 |  |  |  | 3,133 |
|  |  | 8,396,929 |  |  |  | 6,357,982 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration